• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Wnt信号通路在乳腺癌复杂微环境中的作用及治疗潜力展望(综述)

Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review).

作者信息

Sun Meng Xuan, Zhu Han Ci, Yu Yang, Yao Yan, Li Hua Yao, Feng Fu Bin, Wang Qing Yang, Liu Rui Juan, Sun Chang Gang

机构信息

College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China.

State Key Laboratory of Quality Research in Chinese Medicine, and Faculty of Chinese Medicine, Macau University of Science and Technology, Macau 999078, P.R. China.

出版信息

Int J Oncol. 2025 May;66(5). doi: 10.3892/ijo.2025.5742. Epub 2025 Mar 27.

DOI:10.3892/ijo.2025.5742
PMID:40145557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12068849/
Abstract

The focus on breast cancer treatment has shifted from the cytotoxic effects of single drugs on tumor cells to multidimensional multi‑pathway synergistic intervention strategies targeting the tumor microenvironment (TME). The activation of the Wnt signaling pathway in the TME of breast cancer cells serves a key regulatory role in tissue homeostasis and is a key driver of the carcinogenic process. Modulating the crosstalk between the Wnt pathway and TME of breast cancer is key for understanding the biological behavior of breast cancer and advancing the development of novel antitumor drugs. The present review aimed to summarize the complex mechanisms of the Wnt signaling pathway in the breast cancer TME, interactions between the Wnt signaling pathway and components of the breast cancer TME and breast cancer‑associated genes, as well as the interactions between the Wnt signaling pathway and other signaling cascades at the molecular level. Furthermore, the present review aimed to highlight the unique advantages of the Wnt signaling pathway in the macro‑regulation of the TME and the current therapeutic strategies targeting the Wnt signaling pathway, their potential clinical value and future research directions in breast cancer treatment.

摘要

乳腺癌治疗的重点已从单一药物对肿瘤细胞的细胞毒性作用,转向针对肿瘤微环境(TME)的多维度多途径协同干预策略。乳腺癌细胞TME中Wnt信号通路的激活在组织稳态中起关键调节作用,并且是致癌过程的关键驱动因素。调节Wnt通路与乳腺癌TME之间的相互作用,对于理解乳腺癌的生物学行为和推进新型抗肿瘤药物的开发至关重要。本综述旨在总结Wnt信号通路在乳腺癌TME中的复杂机制、Wnt信号通路与乳腺癌TME成分及乳腺癌相关基因之间的相互作用,以及Wnt信号通路与其他信号级联在分子水平上的相互作用。此外,本综述旨在突出Wnt信号通路在TME宏观调控中的独特优势,以及目前针对Wnt信号通路的治疗策略、它们在乳腺癌治疗中的潜在临床价值和未来研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/4ce06dde0063/ijo-66-05-05742-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/cd9907c968d4/ijo-66-05-05742-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/2f063ec0e0b3/ijo-66-05-05742-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/2a6f115bd495/ijo-66-05-05742-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/4ad4f433f9f2/ijo-66-05-05742-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/4ce06dde0063/ijo-66-05-05742-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/cd9907c968d4/ijo-66-05-05742-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/2f063ec0e0b3/ijo-66-05-05742-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/2a6f115bd495/ijo-66-05-05742-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/4ad4f433f9f2/ijo-66-05-05742-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15a2/12068849/4ce06dde0063/ijo-66-05-05742-g04.jpg

相似文献

1
Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review).Wnt信号通路在乳腺癌复杂微环境中的作用及治疗潜力展望(综述)
Int J Oncol. 2025 May;66(5). doi: 10.3892/ijo.2025.5742. Epub 2025 Mar 27.
2
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities.Wnt 信号通路在乳腺癌中的作用:生物学机制、挑战与机遇。
Mol Cancer. 2020 Nov 24;19(1):165. doi: 10.1186/s12943-020-01276-5.
3
New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?原发性骨肿瘤及其微环境中 Wnt/β-连环蛋白信号通路的新见解:开发治疗策略的有前途靶点?
Int J Mol Sci. 2019 Jul 31;20(15):3751. doi: 10.3390/ijms20153751.
4
Wnt signaling in the tumor microenvironment: A driver of brain tumor dynamics.肿瘤微环境中的 Wnt 信号:脑肿瘤动态的驱动因素。
Life Sci. 2024 Dec 1;358:123174. doi: 10.1016/j.lfs.2024.123174. Epub 2024 Oct 28.
5
Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons.Wnt/β-连环蛋白信号通路作为乳腺癌的化疗靶点:利弊更新。
Clin Breast Cancer. 2020 Oct;20(5):361-370. doi: 10.1016/j.clbc.2020.04.004. Epub 2020 Apr 18.
6
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.Wnt/β-catenin 信号通路在肿瘤发生和癌症治疗中的作用。
J Hematol Oncol. 2024 Jun 18;17(1):46. doi: 10.1186/s13045-024-01563-4.
7
Interactions between hedgehog signaling pathway and the complex tumor microenvironment in breast cancer: current knowledge and therapeutic promises. hedgehog 信号通路与乳腺癌复杂肿瘤微环境的相互作用:当前的认识和治疗前景。
Cell Commun Signal. 2024 Sep 9;22(1):432. doi: 10.1186/s12964-024-01812-6.
8
Thiouracil and triazole conjugate induces autophagy through the downregulation of Wnt/β-catenin signaling pathway in human breast cancer cells.硫代尿嘧啶和三唑缀合物通过下调人乳腺癌细胞中的 Wnt/β-连环蛋白信号通路诱导自噬。
IUBMB Life. 2024 Dec;76(12):1377-1391. doi: 10.1002/iub.2917. Epub 2024 Sep 10.
9
Therapeutic targets in the Wnt signaling pathway: Treating cancer with specificity.Wnt信号通路中的治疗靶点:特异性治疗癌症。
Biochem Pharmacol. 2025 Jun;236:116848. doi: 10.1016/j.bcp.2025.116848. Epub 2025 Mar 4.
10
Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance.顺序调节 Wnt/β-catenin 信号通路增强肿瘤内在 MHC I 表达和肿瘤清除。
Gynecol Oncol. 2022 Jan;164(1):170-180. doi: 10.1016/j.ygyno.2021.09.026. Epub 2021 Nov 26.

本文引用的文献

1
Global patterns and trends in breast cancer incidence and mortality across 185 countries.185个国家乳腺癌发病率和死亡率的全球模式及趋势
Nat Med. 2025 Apr;31(4):1154-1162. doi: 10.1038/s41591-025-03502-3. Epub 2025 Feb 24.
2
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer.人表皮生长因子受体2阳性间充质干细胞中CD36的富集导致乳腺癌治疗难治性。
J Exp Clin Cancer Res. 2025 Jan 20;44(1):19. doi: 10.1186/s13046-025-03276-z.
3
Hypoxic BMSC-derived exosomal miR-210-3p promotes progression of triple-negative breast cancer cells via NFIX-Wnt/β-catenin signaling axis.
缺氧的骨髓间充质干细胞衍生的外泌体miR-210-3p通过NFIX-Wnt/β-连环蛋白信号轴促进三阴性乳腺癌细胞的进展。
J Transl Med. 2025 Jan 9;23(1):39. doi: 10.1186/s12967-024-05947-5.
4
Comprehensive pan-cancer analysis indicates UCHL5 as a novel cancer biomarker and promotes cervical cancer progression through the Wnt signaling pathway.全面的泛癌分析表明UCHL5是一种新型癌症生物标志物,并通过Wnt信号通路促进宫颈癌进展。
Biol Direct. 2024 Dec 19;19(1):139. doi: 10.1186/s13062-024-00588-6.
5
A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumors.LRP5/6 拮抗剂 BI 905677 在晚期实体瘤患者中的 I 期剂量递增研究。
ESMO Open. 2024 Nov;9(11):103729. doi: 10.1016/j.esmoop.2024.103729.
6
Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment.肿瘤局部消融(TLA)联合免疫检查点抑制剂在乳腺癌治疗中的当前应用。
Cancer Drug Resist. 2024 Sep 13;7:33. doi: 10.20517/cdr.2024.77. eCollection 2024.
7
Harnessing natural inhibitors of protein synthesis for cancer therapy: A comprehensive review.利用蛋白质合成的天然抑制剂治疗癌症:全面综述。
Pharmacol Res. 2024 Nov;209:107449. doi: 10.1016/j.phrs.2024.107449. Epub 2024 Oct 4.
8
Actin-related protein 2/3 complex subunit 1B promotes ovarian cancer progression by regulating the AKT/PI3K/mTOR signaling pathway.肌动蛋白相关蛋白2/3复合体亚基1B通过调节AKT/PI3K/mTOR信号通路促进卵巢癌进展。
J Transl Int Med. 2024 Oct 1;12(4):406-423. doi: 10.2478/jtim-2024-0025. eCollection 2024 Sep.
9
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer.crVDAC3 通过抑制 HSPB1 泛素化来减轻铁死亡,并赋予 HER2 低表达乳腺癌对曲妥珠单抗-德鲁替康的耐药性。
Drug Resist Updat. 2024 Nov;77:101126. doi: 10.1016/j.drup.2024.101126. Epub 2024 Aug 6.
10
T cell dysfunction and therapeutic intervention in cancer.T 细胞功能障碍与癌症的治疗干预。
Nat Immunol. 2024 Aug;25(8):1344-1354. doi: 10.1038/s41590-024-01896-9. Epub 2024 Jul 18.